Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463042 · ClinicalTrials.gov registry record · NA
Intermittent Hypoxia and Balance Control
A NA study of Intermittent Hypoxia and Normoxia, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT05463042: Completed NA study of Intermittent Hypoxia and Normoxia, sponsored by University of Texas at Austin.
NCT05463042 is a NA study of Intermittent Hypoxia and Normoxia that has completed, run by University of Texas at Austin. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05463042, a NA study of Intermittent Hypoxia and Normoxia, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the effect of acute mild intermittent hypoxia on ankle plantarflexor muscle output during balance regulation and walking in younger and older adults. Fifteen younger adults and 15 older adults will be recruited to participate in the cross-over design study that requires 2 visits (at least 1-week apart). Participants will be pseudo-randomly assigned to receive either intermittent hypoxia or sham during the first visit, and then switch over to receive sham or intermittent hypoxia during the 2nd visit. Muscle activation patterns and kinetic and kinematics during standing and walking will be recorded before and after the intermittent hypoxia/sham. It is hypothesized that compared to the sham condition, both younger and older participants will show greater increases in ankle plantarflexor muscle activation during gait and balance assessments following intermittent hypoxia.
Primary Outcome
changes in peak soleus muscle EMG magnitude following perturbation onset during standing from pre to post intermittent hypoxia will be calculated
Conditions Studied
Interventions
- BEHAVIORAL Intermittent Hypoxia
- BEHAVIORAL Normoxia (sham)
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-08-21 |
| Phase | NA |
What the finished NCT05463042 record still lists
NCT05463042 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Intermittent Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Hypoxia is the first listed.
NCT05463042 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05463042 about?
NCT05463042 is a clinical study titled "Intermittent Hypoxia and Balance Control". This study aims to determine the effect of acute mild intermittent hypoxia on ankle plantarflexor muscle output during balance regulation and walking in younger and older adults. Fifteen younger adults and 15 older adults will be recruited to participate in the cross-over design study that requires ...
What is the current status of trial NCT05463042?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2022-09-01. Estimated completion is 2023-08-21.
What conditions does trial NCT05463042 study?
This clinical trial studies the following conditions: Intermittent Hypoxia, Normoxia.
What interventions are being tested in trial NCT05463042?
The interventions under investigation include: Intermittent Hypoxia (BEHAVIORAL), Normoxia (sham) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05463042?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463042 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05463042's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI